Skip to main content
. Author manuscript; available in PMC: 2010 Feb 10.
Published in final edited form as: Vaccine. 2009 May 29;27(43):6088. doi: 10.1016/j.vaccine.2009.05.016

Fig. 5.

Fig. 5

Viral load (VL) rebound during analytic treatment interruption. The horizontal dotted line represents a VL of 5000c/mL. The red lines (all in arm A) designate VL curves for subjects who had a setpoint VL<5000 c/mL. Three subjects restarted ART or went off-study prior to completion of the ATI (these subjects are designated with a “*” next to their VL curve). One subject resumed therapy after week 10 of the ATI.